abstract |
The present invention relates to a parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate (generically known as clomethiazole edisylate) having improved antimicrobial properties in addition to physical, chemical and microbiological stability as well as biological compatibility. |